Müzeyyen Aybüke Yayla1, Begüm Arda1, Özge Çağlar1,2, Oytun Erbaş3

1ERBAS Institute of Experimental Medicine, Illinois, USA & Gebze, Turkey
2Department of Chemistry, Selçuk University Faculty of Science, Konya, Turkey
3Department of Physiology, Medical Faculty of Demiroğlu Bilim University, Istanbul, Turkey

Keywords: nxiety, attention deficit and hyperactivity, autism spectrum disorder, depression, disorder, oxytocin, peptide hormones, psychiatric diseases

Abstract

Hormones are classified as steroid, protein, peptide and polypeptide hormones according to their chemical structures. Peptide and polypeptide hormones: Oxytocin, leptin, ghrelin, corticotropin-releasing hormone, gonadal regulating hormone, vasopressin, cholecystokinin. The pharmaceutical industry has generally made great efforts to develop complex peptide hormone products, and studies have been conducted on different uptake pathways of peptide hormones in psychiatric diseases. Psychiatric diseases, on the other hand, are disorders that change an individual's behavior and lifestyle as a result of the mental and mental problems experienced by the individual. In this review, the effects of peptide hormones on psychiatric diseases such as autism spectrum disorder, attention deficit and hyperactivity disorder (ADHD), depression and anxiety disorder, and the applicability of peptide hormones as therapy will be discussed.

Cite this article as: Aybüke Yayla M, Arda B, Çağlar Ö, Erbaş O. Peptide Hormones and Neurodegenerative Diseases. JEB Med Sci 2021;2(1):62-75.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.